Please login to the form below

Not currently logged in
Email:
Password:

Hey You! campaign targets over 60s at high risk of stroke

Bayer launches atrial fibrillation awareness drive starring rock and roll
Bayer Hey You!

Bayer is using rock and roll to raise awareness about the risk of stroke in patients with atrial fibrillation, launching the 'Hey You!' campaign to get over 60s thinking about their heart health.

Teaming up with rock session drummer Clem Cattini and several UK heart charities, Bayer aims to improve awareness of the signs of an irregular heartbeat and boost stroke prevention in over 60s.

The music-centred campaign encourages people to pay attention to the rhythm of their heart and talk to their doctor if the beat doesn't feel quite right - a vital first step in identifying AF and reducing stroke risk.

Patients with AF are six times more likely to have a stroke, according to research by the ABPI, with half of those who have a stroke not surviving more than 12 months. The remainder often face heart failure, poor mental health and reduced quality of life.

Eve Knight, co-founder and chief executive of AntiCoagulation Europe - one of the 'Hey You!' campaign partners - said: “AF is the most common abnormal heart rhythm in the UK, significantly increasingly the risk of stroke.

“Yet 50% of people living with the condition don't realise they have it, and many don't recognise the symptoms until they have a life-threatening stroke.

“It's important we're supporting AF patients by doing all we can to reduce stroke risk, that is why AntiCoagulation Europe is delighted to be involved in the 'Hey You!' Campaign.

Around 1.5 million people in the UK are affected by AF, and Bayer hopes that increased awareness and better management of AF-related stroke risk could prevent up to 7,000 strokes and 2,000 deaths each year.

While most likely to affect those aged 65 and over, approximately 1 in every 200 50-59 year-olds has AF and the number of people in the UK with the condition is expected to double by 2050.

Article by
Rebecca Clifford

21st November 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics